Peterson P K, Anderson R C
Am J Med. 1986 Jul 28;81(1A):2-10. doi: 10.1016/0002-9343(86)90509-7.
Despite dramatic improvements in patient and renal allograft survival, infections continue to be an important cause of post-transplantation morbidity and mortality. Most serious infections manifest clinically as febrile diseases, and immunosuppression-induced compromised cell-mediated immunity is the basis for the predominance of infections due to opportunistic intracellular microorganisms. Diagnostic evaluation is guided by the timing of fever after transplantation, epidemiologic factors, and evidence of specific organ system involvement. Although current therapy of bacterial and parasitic infections is usually effective, the management of deep-seated fungal infections remains highly unsatisfactory. Cytomegalovirus disease, the single most important infection in some transplant centers, frequently presents as a self-limited viral syndrome; however, multiple organs may be affected. New measures for the rapid diagnosis and treatment of this viral infection hold promise. A number of recommendations have been proposed to prevent infections in renal transplant recipients; however, continued progress will depend primarily upon further refinements in immunosuppressive therapy.
尽管患者和肾移植受者的存活率有了显著提高,但感染仍然是移植后发病和死亡的重要原因。大多数严重感染在临床上表现为发热性疾病,免疫抑制导致的细胞介导免疫受损是机会性细胞内微生物感染占主导地位的基础。诊断评估以移植后发热时间、流行病学因素以及特定器官系统受累的证据为指导。虽然目前对细菌和寄生虫感染的治疗通常有效,但深部真菌感染的管理仍然很不理想。巨细胞病毒病是一些移植中心最重要的单一感染,常表现为自限性病毒综合征;然而,多个器官可能会受到影响。针对这种病毒感染的快速诊断和治疗的新措施有望取得成效。已经提出了一些预防肾移植受者感染的建议;然而,持续的进展将主要取决于免疫抑制治疗的进一步完善。